Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
22 hedge funds and large institutions have $1.97M invested in Sophiris Bio, Inc. in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 9 closing their positions.
21% less capital invested
Capital invested by funds: $2.47M → $1.97M (-$509K)
24% less funds holding
Funds holding: 29 → 22 (-7)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hikari Power
Tokyo,
Japan
|
+$87.6K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$16.7K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$12.9K |
| 4 |
Jane Street
New York
|
+$10.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$173 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$102K |
| 2 |
BlackRock
New York
|
-$72K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$34K |
| 4 |
VF
Virtu Financial
New York
|
-$24K |
| 5 |
Bank of New York Mellon
New York
|
-$23K |
SPHS Hedge Fund Activity: Q2 2019 in Review
22 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q2 2019, worth a combined $1.97M — down 21% from $2.47M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SPHS and 2 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Hikari Power, adding an estimated $87.6K. The largest seller was Vanguard Group, cutting an estimated $102K.
- 22 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q2 2019, down from 29 in Q1 2019.
- Funds reported $1.97M of Sophiris Bio, Inc. stock for Q2 2019, down 21% quarter-over-quarter.
- 2 funds opened new Sophiris Bio, Inc. positions in Q2 2019 and 9 closed out, a net change of -7 holders.
- The largest Sophiris Bio, Inc. buyer in Q2 2019 was Hikari Power, an estimated $87.6K added.
- The largest Sophiris Bio, Inc. seller in Q2 2019 was Vanguard Group, an estimated $102K sold.
Based on aggregated 13F filings for Q2 2019.